Allergy and Immunology, Allergy · New York, NY
NPI
1487804019
Since 2008
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
353 E 17th St, Apt 4b
New York, NY, 10003
Phone (212) 217-0525
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
2,631 services
Medicare patients, 2024
206
Average age 75
Drug cost, 2024
$1.2M
1,794 prescriptions
Company payments, 2025
$1,186
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Kochin was code 95004 (test - miscellaneous), 1,008 times for 21 patients. In total Anna Kochin billed 2,631 services in 21 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,008 | 21 | $3.54 | $3,564 |
| 95165 Treatment - Miscellaneous | Office | 744 | 26 | $13.22 | $9,838 |
| 99213 Office E&M - Established | Office | 440 | 149 | $80.28 | $35K |
| 95117 Treatment - Miscellaneous | Office | 137 | 27 | $11.36 | $1,557 |
| 99212 Office E&M - Established | Office | 122 | 28 | $50.52 | $6,163 |
| 99203 Office E&M - New | Office | 55 | 55 | $98.77 | $5,432 |
| 94060 Pulmonary Function Testing | Office | 20 | 16 | $35.65 | $713 |
By year: 2022 $64K for 2,166 services; 2023 $60K for 2,414 services; 2024 $65K for 2,631 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 36 | 35 | $8.40 | $302 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Kochin prescribed most often to Medicare patients was Azelastine Hcl, with 227 prescriptions and refills. In total Anna Kochin wrote 1,794 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 227 | 249 | 63 | $4,164 |
| Opzelura Ruxolitinib Phosphate | 154 | 154 | 33 | $294K |
| Eucrisa Crisaborole | 150 | 150 | 23 | $110K |
| Montelukast Sodium Generic | 146 | 146 | 32 | $619 |
| Levocetirizine Dihydrochloride Generic | 128 | 130 | 30 | $427 |
| Fluticasone Propionate Generic | 108 | 110 | 35 | $762 |
| Ryaltris Olopatadine Hcl/Mometasone | 107 | 112 | 22 | $25K |
| Symbicort Budesonide/Formoterol Fumarate | 87 | 89 | 14 | $19K |
| Tacrolimus Generic | 75 | 75 | 15 | $7,629 |
| Ketoconazole Generic | 71 | 71 | 16 | $4,920 |
| Spiriva Respimat Tiotropium Bromide | 61 | 61 | Under 11 | $29K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 40 | 40 | 12 | $1,257 |
| Tezspire Tezepelumab-Ekko | 37 | 43 | Under 11 | $186K |
| Hydroxyzine Hcl Generic | 35 | 35 | 14 | $153 |
| Ventolin Hfa Albuterol Sulfate | 34 | 34 | Under 11 | $1,799 |
Brand drugs: 896 claims; generic drugs: 898 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Kochin $1,186 ($1,186 in general payments such as food, travel and fees) from 16 companies. The largest payer was Genzyme Corporation with $367.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 17 | $367 |
| GlaxoSmithKline, LLC. GSK | 14 | $288 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $89.14 |
| CSL Behring CSL.AX | 3 | $86.62 |
| Incyte Corporation INCY | 3 | $68.48 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $46.05 |
| BioCryst US Sales Co., LLC | 1 | $36.81 |
| Genentech USA, Inc. ROG.SW | 1 | $33.76 |
| Optinose US, Inc. | 1 | $25.34 |
| Exact Sciences Corporation EXAS | 1 | $25.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.